Page 3 - Best Follicular lymphoma doctors: TOP 73 doctors

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Ofer Spielberg is a dedicated oncohematologist specializing in blood cancers like follicular lymphoma at Assuta Medical Center.

• Focuses exclusively on the diagnosis and treatment of hematological malignancies
• Part of a leading oncology department in Israel
• Expertise in modern treatment protocols for lymphoma

Recognized by Forbes as one of the best doctors in 2018 – Dr. Stepensky has performed over 3,500 bone marrow transplants.

• 28 years of experience of experience in pediatric hematology
• Specializes in treating rare blood cancers in children
• Patients and families refer to her as 'the one who transplants life'
• Works at Hadassah Medical Center

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Professor Bosch is a world-renowned leader in Chronic Lymphocytic Leukemia (CLL) and lymphoproliferative disorders, with innovations in hematological disease analysis and treatments.

• Leads clinical trials area for CLL and lymphomas
• Published over 100 articles in top scientific journals
• Head of Hematology at IOB Institute of Oncology
• Conducts both clinical and basic research on CLL

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Specializes in the treatment of lymphomas at Rambam Medical Center.

• Specialist in hematology
• Focused expertise in lymphoma treatments
• Works at a leading medical center

Prof. Dr. Serdar Bedii Omay has published 65+ scientific articles in hematology and bone marrow transplantation, with extensive experience in the field.

• Trained at Japan's Mie Medical Faculty in molecular hematology
• Professor of Hematology at Karadeniz Technical University
• Specialized in internal medicine and hematology since 1990
• Authored 112 meeting papers and 34 conference presentations

Associate Professor in Hematology with 50+ publications – Dr. Eren specializes in follicular lymphoma at Biruni University Hospital.

• Completed Hematology subspecialty training at Istanbul Training and Research Hospital
• Member of European Society of Hematology and Turkish Hematology Association
• Recipient of Young Researcher Award at National Hematology Congress
• Fluent in English for international patient consultations

Dr. Apak specializes in pediatric hematology-oncology with 26 years of experience of experience, including CAR T-cell therapy and bone marrow transplantation at Biruni University Hospital.

• Head of Pediatric Hematology-Oncology Division at Istanbul University-Cerrahpaşa
• Published 75 international papers on pediatric oncology
• Assistant editor for Turkish Pediatrics Archives Periodical
• Board member of Turkish Pediatric Society

Prof. Baytan specializes in childhood cancers like follicular lymphoma, with over 34 years of experience of experience in pediatric hematology.

• Trained at Uludağ University, a leading institution in Turkey
• Published 15 articles in international refereed journals
• Expert in leukemia, lymphoma, and childhood bleeding diseases
• Authored 3 books on pediatric hematology

Specializes in lymphoma treatment at Liv Hospital Vadistanbul – focusing on hematological malignancies like follicular lymphoma.

• Professor with extensive experience in hematology
• Worked in stem cell transplantation units and therapeutic apheresis
• Education and administrative roles in top Turkish hospitals
• Fellowship-trained at Ankara Oncology Hospital

Associate Professor Ali Hakan Kaya specializes in hematology and stem cell transplants, with extensive experience in treating follicular lymphoma.

• Completed hematology subspecialty training at Ankara Oncology Training and Research Hospital
• Member of multiple prestigious societies including the Hematologic Oncology Society
• Recipient of several awards for research in hematologic oncology
• Works at Biruni University Hospital, a leading medical institution